Relapsed/Refractory Leukemia
3 clinical trials · Condition
◉ Watch Relapsed/Refractory Leukemia
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia (NCT00780143) | PharmaMar | 2007-11-01 |
| Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL) (NCT00724360) | Nantes University Hospital | 2006-11-01 |
Track Relapsed/Refractory Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.